HealthcareOn the MoveEndocyte set for opening gap downJun. 18, 2014 9:07 AM ETEndocyte, Inc. (ECYT) StockECYTBy: Douglas W. House, SA News EditorShares of Endocyte (NASDAQ:ECYT) are down 14% premarket on heavy volume in response to Merck's exit from vintafolide.Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgECYT--Endocyte, Inc.Trending AnalysisTrending News